1.
Natural products as promising drug candidates for the
treatment of hepatitis B and C.
Wohlfarth C, Efferth T.
Acta Pharmacol Sin. 2008 Dec 8. [Epub ahead of print]
PMID: 19060918 [PubMed - as supplied by publisher]
2.
The Design, Synthesis, and Antiviral Activity of
4'-Azidocytidine Analogues against Hepatitis C Virus Replication: The Discovery
of 4'-Azidoarabinocytidine.
Smith DB, Kalayanov G, Sund C, Winqvist A, Pinho P, Maltseva T, Morisson V,
Leveque V, Rajyaguru S, Pogam SL, Najera I, Benkestock K, Zhou XX, Maag H,
Cammack N, Martin JA, Swallow S, Johansson NG, Klumpp K, Smith M.
J Med Chem. 2008 Dec 5. [Epub ahead of print]
PMID: 19055482 [PubMed - as supplied by publisher]
3.
Discovery of novel, potent and bioavailable
proline-urea based macrocyclic HCV NS3/4A protease inhibitors.
Vendeville S, Nilsson M, de Kock H, Lin TI, Antonov D, Classon B, Ayesa S,
Ivanov V, Johansson PO, Kahnberg P, Eneroth A, Wikstrom K, Vrang L, Edlund M,
Lindström S, Van de Vreken W, McGowan D, Tahri A, Hu L, Lenz O, Delouvroy F,
Van Dooren M, Kindermans N, Surleraux D, Wigerinck P, Rosenquist A, Samuelsson
B, Simmen K, Raboisson P.
Bioorg Med Chem Lett. 2008 Dec 1;18(23):6189-93. Epub 2008 Oct 5.
PMID: 18954982 [PubMed - in process]
4.
Non-nucleoside inhibitors of the hepatitis C virus
NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one
derivatives.
Rawal RK, Katti SB, Kaushik-Basu N, Arora P, Pan Z.
Bioorg Med Chem Lett. 2008 Dec 1;18(23):6110-4. Epub 2008 Oct 8.
PMID: 18947995 [PubMed - in process]
5.
Preclinical characteristics of the hepatitis C virus
NS3/4A protease inhibitor ITMN-191 (R7227).
Seiwert SD, Andrews SW, Jiang Y, Serebryany V, Tan H, Kossen K, Rajagopalan PT,
Misialek S, Stevens SK, Stoycheva A, Hong J, Lim SR, Qin X, Rieger R, Condroski
KR, Zhang H, Do MG, Lemieux C, Hingorani GP, Hartley DP, Josey JA, Pan L,
Beigelman L, Blatt LM.
Antimicrob Agents Chemother. 2008 Dec;52(12):4432-41. Epub 2008 Sep 29.
PMID: 18824605 [PubMed - in process]